# OnCo record daehwa-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/daehwa-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "daehwa-pharmaceutical" ;
  schema:name "Daehwa Pharmaceutical"@en ;
  schema:alternateName "Daehwa Pharmaceutical Co., Ltd."@en, "Dae Hwa Pharm"@en, "대화제약"@en ;
  schema:description "Daehwa is a Korean pharmaceutical company whose oral paclitaxel (Liporaxel) was approved in Korea for gastric cancer after a phase 3 trial it led, one of the few oral formulations of a taxane to reach the market."@en ;
  schema:url <https://onco.cc/companies/daehwa-pharmaceutical/>, <http://www.dhpharm.co.kr> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.dhpharm.co.kr>, <https://clinicaltrials.gov/search?lead=Daehwa%20Pharmaceutical%20Co.%2C%20Ltd.>, <https://www.wikidata.org/wiki/Q56583329> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct03315364/> .